MoneyWorks4Me

Suven Pharmaceuticals informs about BRSR

23 Nov 2023 Evaluate
Suven Pharmaceuticals has informed that the present report has been compiled in accordance with the guidelines set forth by the Securities and Exchange Board of India (SEBI) for Business Responsibility and Sustainability Reporting (BRSR). Its principal aim is to demonstrate enhanced transparency regarding the ways in which enterprises generate value by actively contributing to a sustainable economy. The report highlights its unwavering dedication to creating long-term value for its stakeholders while simultaneously promoting sustainable development.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..